RNA Interference: Nobel Lecture by Fire & Mello | Gene Silencing

Added:

Antisense Oligonucleotides and CRISPRi as Superior Gene Silencing Alternatives

While RNA interference (RNAi) is a groundbreaking mechanism for post-transcriptional gene silencing, it faces competition and criticism from alternative technologies. A major limitation of RNAi is its propensity for off-target effects, where small interfering RNAs (siRNAs) inadvertently silence unintended genes sharing partial sequence homology. Furthermore, RNAi relies on the host cell's endogenous machinery (such as DICER and the RISC complex), which can become saturated and disrupt natural cellular pathways. In contrast, alternative platforms like Antisense Oligonucleotides (ASOs) and CRISPR Interference (CRISPRi) offer distinct advantages. ASOs bind to target mRNA and recruit RNase H for degradation, bypassing the host's RNAi machinery entirely and reducing saturation risks. CRISPRi targets the genome at the transcriptional level using a catalytically inactive Cas9 (dCas9) fused to transcriptional repressors. This blocks transcription at the DNA level, providing highly specific, robust, and reversible gene silencing without the transient and off-target drawbacks of RNAi-mediated post-transcriptional degradation.

The Central Dogma of Molecular Biology, specifically how genetic information flows from DNA to RNA to functional proteins.
The basic structure and types of nucleic acids, including the chemical differences between DNA and RNA, and single-stranded vs. double-stranded RNA.
The fundamental principles of gene expression and regulation in eukaryotic organisms.
An introductory understanding of model organisms, particularly Caenorhabditis elegans, and their historical role in genetic research.
The precise biochemical pathway of RNA interference, focusing on the roles of the Dicer enzyme, Argonaute proteins, and the RNA-induced silencing complex (RISC).
Therapeutic applications of RNAi, including the development of small interfering RNAs (siRNAs) and microRNAs (miRNAs) as targeted drug therapies.
The use of RNAi in reverse genetics and functional genomics to study gene function through systematic gene knockdown.
A comparative study of gene silencing via RNAi versus permanent genome editing using CRISPR-Cas9 technologies.
6K views119likes34:30@NobelPrizeOriginal Release: 2022-04-29

RNA interference (RNAi) is a fundamental cellular mechanism where double-stranded RNA molecules trigger the silencing of specific genes, providing a powerful tool for studying gene function and potentially developing therapeutic applications; this discovery, made by Andrew Fire and Craig Mello, demonstrates how basic scientific research can lead to transformative technologies while highlighting the importance of maintaining curiosity, questioning established ideas, and supporting fundamental research alongside applied studies.